Scientech Research LLC Intra Cellular Therapies, Inc. Transaction History
Scientech Research LLC
- $485 Billion
- Q2 2024
A detailed history of Scientech Research LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Scientech Research LLC holds 35,270 shares of ITCI stock, worth $3.15 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
35,270Holding current value
$3.15 Million% of portfolio
0.5%Shares
1 transactions
Others Institutions Holding ITCI
# of Institutions
403Shares Held
87.5MCall Options Held
309KPut Options Held
302K-
Vanguard Group Inc Valley Forge, PA9.61MShares$857 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$564 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.72MShares$332 Million1.37% of portfolio
-
Jpmorgan Chase & CO New York, NY3.44MShares$307 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY3MShares$268 Million2.8% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $8.42B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...